Article (Scientific journals)
Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions.
WITHOFS, Nadia; Kumar, Rakesh; Alavi, Abass et al.
2022In PET Clinics, 17 (3), p. 327-342
Peer Reviewed verified by ORBi
 

Files


Full Text
CPET 759.pdf
Author postprint (2.12 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Brain tumor; FDG; FDOPA; FET; Neuro-oncology; PET; Amino Acids; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography/methods; Brain Neoplasms/diagnostic imaging; Glioma/diagnostic imaging; Glioma/pathology; Radiation; Radiology, Nuclear Medicine and Imaging
Abstract :
[en] MRI is the first-choice imaging technique for brain tumors. Positron emission tomography can be combined together with multiparametric MRI to increase diagnostic confidence. Radiolabeled amino acids have gained wide clinical acceptance. The reported pooled specificity of [18F]FDG positron emission tomography is high and [18F]FDG might still be the first-choice positron emission tomography tracer in cases of World Health Organization grade 3 to 4 gliomas or [18F]FDG-avid tumors, avoiding the use of more expensive and less available radiolabeled amino acids. The present review discusses the additional value of positron emission tomography with a focus on [18F]FDG and radiolabeled amino acids.
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
WITHOFS, Nadia ;  Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
Kumar, Rakesh;  Diagnostic Nuclear Medicine Division, All India Institute of Medical Sciences, New Delhi 110029, India
Alavi, Abass;  Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
HUSTINX, Roland  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
Language :
English
Title :
Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions.
Publication date :
July 2022
Journal title :
PET Clinics
ISSN :
1556-8598
eISSN :
1879-9809
Publisher :
W.B. Saunders, United States
Volume :
17
Issue :
3
Pages :
327-342
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 06 July 2022

Statistics


Number of views
121 (6 by ULiège)
Number of downloads
202 (4 by ULiège)

Scopus citations®
 
3
Scopus citations®
without self-citations
3
OpenCitations
 
2

Bibliography


Similar publications



Contact ORBi